口服纳米配方用于子宫内膜腺癌的内分泌治疗
Minghua Cui1, Yuehui Liu2, Yangyang Liu2
1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun 130117, China; Gynecology Department, Affliated Hospital of Changchun University of Chinese Medicine, Changchun 130117, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|September 7, 2024
概括
对子宫内膜腺癌 (EEC) 的口服内分泌疗法在药物输送方面面临挑战. 纳米技术提供了有前途的口服纳米配方,以提高治疗效率和患者的治疗结果.
科学领域:
- 妇科 妇科医生 妇科
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 子宫内膜癌,特别是子宫内膜状子宫内膜癌 (EEC),是妇女的重大全球健康问题.
- 高复发率和生育保护需求使EEC治疗复杂化,使口服内分泌疗法成为主要方式.
- 目前的口服内分泌疗法 (孕激素,SERA,芳香酶抑制剂) 具有较差的溶解性和生物可用性.
研究的目的:
- 审查子宫内膜状子宫内膜癌 (EEC) 的致病性.
- 探索口服纳米配方在增强内分泌疗法的潜力.
- 突出纳米载体系统,以改善在EEC治疗中的药物输送.
主要方法:
- 关于EEC病原体的文献综述.
- 对EEC目前口服内分泌疗法的分析.
- 探索纳米技术在药物输送中的应用.
主要成果:
- 像纳米球,纳米囊和等纳米载体可以克服可溶性和利用问题.
- 这些纳米载体保护药物免受清除,并增强特定部位的输送.
- 纳米配方是一种有希望的策略,可以提高口服内分泌疗法的疗效.
结论:
- 纳米技术为在欧洲经济共同体提供内分泌疗法的创新解决方案.
- 口服纳米配方有可能改善治疗结果并解决当前的治疗局限性.
- 对纳米载体系统的进一步研究对于推进EEC管理至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


